SEC Filings

Form 8-K
KINDRED BIOSCIENCES, INC. filed this Form 8-K on 05/07/2018
Document Outline
Entire Document (321 KB)
Subdocument 1 - 8-K - 8-K
Page 1 - UNITED STATES
Page 2 - Item 1.01Entry into a Material Definitive Agreement.
Page 3 - N/A
Page 4 - SIGNATURE
Subdocument 2 - EX-5.1 - TG OPINION
Page 1 - EXHIBIT 5.1
Page 2 - N/A
Page 3 - N/A
Subdocument 3 - EX-10.1 - SALES AGREEMENT
Page 1 - EXHIBIT 10.1
Page 2 - Securities ActCommissionExchange ActProspectus SupplementRegistration StatementProspectusIncorporate
Page 3 - Schedule 3,Schedule 3Section 13Schedule 2Sections 23
Page 4 - provided, however
Page 5 - Section 11(a)
Page 6 - No Misstatement or Omission.
Page 7 - Financial Information.GAAP
Page 8 - Material Adverse Effect
Page 9 - S-3 Eligibility
Page 10 - No Consents Required.FINRA
Page 11 - No Litigation.
Page 12 - Broker/Dealer Relationships.
Page 13 - Environmental Laws.Environmental Laws
Page 14 - Sarbanes-Oxley Act.
Page 15 - Underwriter Agreements.
Page 16 - Status Under the Securities Act.
Page 17 - Compliance with Applicable LawsApplicable LawsEMAAuthorizations
Page 18 - Compliance Program
Page 19 - Stock Transfer Taxes.
Page 20 - Section 7(a)
Page 21 - provided, however
Page 22 - provided, however
Page 23 - Representation Date
Page 24 - Comfort Letter.Section 7(l)(iii)Comfort LettersSection 7(n)Initial Comfort Letter
Page 25 - Representations and Covenants of the Agents.
Page 26 - No Misstatement or Material Omission.
Page 27 - Representation Certificate.Section 7(1)Section 7(1)
Page 28 - Section 11(d)
Page 29 - Section 11
Page 30 - Section 11(d)Section 11(d)Section 11(d)Section 11(c)Section 11(d)Section 11(d)Section 11(d)Section 1
Page 31 - Representations and Agreements to Survive Delivery.
Page 32 - Section 9Section 11Section 12Section 18Section 19
Page 33 - Business Day
Page 34 - Electronic NoticeSection 14Nonelectronic Notice
Page 35 - CONSENT TO JURISDICTION.
Page 36 - Absence of Fiduciary Relationship.
Page 37 - Rule 172Rule 405Rule 415Rule 424Rule 424(b)Rule 430BRule 433
Page 38 - KINDRED BIOSCIENCES, INC.
Page 39 - SCHEDULE 1
Page 40 - SCHEDULE 2
Page 41 - SCHEDULE 3
Page 42 - SCHEDULE 6(g)
Page 43 - EXHIBIT 7(1)
Page 44 - EXHIBIT 23
Subdocument 4 - EX-99.1 - PRESS RELEASE
Page 1 - EXHIBIT 99.1
Page 2 - EXHIBIT 99.1